MTOR and cancer: Metformin can target the mTOR pathway by activating AMPK to inhibit tumorigenesis by decreasing cancer cell proliferation (Gwinn et al., 2008; Emami Riedmaier et al., 2013; Sinnett-Smith et al., 2013).